Ms. Andor will lead the Company’s expanding Clinical Operations function in support of the ongoing Phase 3 program evaluating oral levosimendan (TNX-103) for the treatment of pulmonary hypertension ...
Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...
In our comprehensive fellowship program, you will receive a broad range of hands-on clinical experience and ... and simulation sessions for teaching pulmonary and critical procedures such as airway ...
News Medical on MSN11d
Singapore’s respiratory health gets boost with $10 million research grantCentre, a national research platform led by Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), will lead a multi-institutional research ...
Learn more about whether The Ensign Group, Inc. or Privia Health Group, Inc. is a better investment based on AAII's A+ ...
Current epidemiology and treatment practices for pulmonary sarcoidosis in the U.S. based on real-world evidence ...
A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...
Imbert brings 25 years of strategic clinical to commercial-stage ... the Company's current and future commercial plans and strategies, including the Company's goal of becoming the leader in the ...
Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback